Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

2020 Cell 2,230 citations

Keywords

BiologyVero cellSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyAngiotensin-converting enzyme 2CoronavirusRecombinant DNAReceptorCoronavirus disease 2019 (COVID-19)LungOrganoidBetacoronavirusHEK 293 cells2019-20 coronavirus outbreakVirusImmunologyGeneCell biologyInternal medicineMedicineGenetics

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
181
Issue
4
Pages
905-913.e7
Citations
2230
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2230
OpenAlex

Cite This

Vanessa Monteil, Hyesoo Kwon, Patricia Prado et al. (2020). Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell , 181 (4) , 905-913.e7. https://doi.org/10.1016/j.cell.2020.04.004

Identifiers

DOI
10.1016/j.cell.2020.04.004